Skip to main content
FDA updates label for controversial Alzheimer’s drug aducanumab (Aduhelm)
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
FDA updates label for controversial Alzheimer’s drug aducanumab (Aduhelm)
User login
Username
Password
Reset your password
Concept
Lead
score
Alzheimer Disease
1
0.95
Aducanumab
0
1
Food and Drug Administration (FDA)
0
0.9
Mild Cognitive Impairment
0
0.46
Clinical Research
0
0.42
Dementia
0
0.21
Cognitive Impairment
0
0.15
Amyloid-Beta
0
0.1
Grant
0
0.1
Impairment
0
0.1
Specialty
Lead
score
Neurology & Neurosurgery
1
1
Pharmacist
0
1
Psychiatry
0
0.8
Internal Medicine
0
0.48